-
Bacterial therapy shows early promise in patients with advanced solid tumours
europeanpharmaceuticalreview
April 19, 2019
Researchers have presented results of a Phase I clinical trial using bacterial Clostridium novyi-NT spores to target advanced solid tumours…
-
Trial Results Unclear for Benefit of Longer Hemodialysis Sessions
drugs
April 19, 2019
Trial Results Unclear for Benefit of Longer Hemodialysis Sessions.
-
Durvalumab improves survival of non-small cell lung cancer patients
europeanpharmaceuticalreview
April 18, 2019
Moffitt researchers conducted a Phase III trial which found durvalumab to increase the survival of patients with non-small cell lung cancer…
-
Lead Pharma Announces Start of Phase I Clinical Trials with SAR441169 Candidate Treatment for Psoriasis
b3cnewswire
April 17, 2019
Sanofi, Lead Pharma’s collaborative partner in the development of SAR441169...
-
Vetter's Skokie Facility Expansion Nears Completion
b3cnewswire
April 17, 2019
Facility growth is necessary to help meet customer demands and new product requirements.
-
Provention Bio Initiates Phase 3 PROTECT Clinical Trial with PRV-031 (Teplizumab) in Patients with Recent Onset Type 1 Diabetes
drugs
April 17, 2019
Provention Bio Initiates Phase 3 PROTECT Clinical Trial with PRV-031 (Teplizumab) in Patients with Recent Onset Type 1 Diabetes.
-
USPSTF: Evidence Lacking for Elevated Lead Level Screening
drugs
April 17, 2019
USPSTF: Evidence Lacking for Elevated Lead Level Screening.
-
Mixed Effects Observed for Workplace Wellness Program
drugs
April 17, 2019
Mixed Effects Observed for Workplace Wellness Program.
-
Clinical trials: Breaking the taboo
expressbpd
April 16, 2019
Clinical trials: Breaking the taboo.
-
High-dose vitamin D shows benefit in patients with advanced colorectal cancer
worldpharmanews
April 16, 2019
High-dose vitamin D shows benefit in patients with advanced colorectal cancer...